Ibj.com2d
New life sciences consortium aims to give Indiana researchers better access to health data
AnalytiXIN has launched a consortium designed to give Indiana researchers better access to health care data—potentially ...
Investors lose their appetite for the obesity trade
Linden Thomson, senior fund manager at Candriam, notes that weight-loss drugs have become the driver of healthcare investing. “The obesity opportunity is one that people can really understand and has ...
Eli Lilly: Market Overreacted
Eli Lilly's diverse portfolio shows broad growth, with significant contributions from oncology and other therapeutic areas.
Jim Cramer Says ‘Eli Lilly and Company (LLY)’s Drug Is Superior In Terms Of Weight Reduction At The Same Dose’
We recently compiled a list of the Jim Cramer Recently Discussed These 17 Stocks And Chinese Hackers. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands ...
Eli Lilly Missed Sales Expectations Again. Should Investors Be Worried?
In the first half of 2024, it seemed Eli Lilly (NYSE: LLY) could do no wrong. Is Eli Lilly a good stock to buy on the dip? On ...